VTWG Vanguard Russell 2000 Growth ETF
Quote as of Oct 13, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 258.28 | Day Range | 255.59 – 258.35 |
| 52-Week Range | 218.84 – 289.14 | Volume | 17.70K |
| Avg Volume | 21.78K | AUM | $1.70B (Oct 13, 2026) |
| Expense Ratio | 0.06% | Yield (TTM) | 0.68% |
| NAV | 258.17 | Premium/Discount | -0.76% indicative |
| Inception | Sep 20, 2010 | Holdings | 1129 |
| Issuer | Vanguard | Exchange | NASDAQ |
| Category | Us Small Cap | Index Tracked | Russell 2000 |
| CUSIP | 92206C623 | ISIN | US92206C6232 |
| Management | Not stated in source data | ||
About this ETF
This exchange-traded fund primarily allocates capital to equities featured in the Russell 2000 Growth Index. This benchmark is recognized for its extensive diversification and its focus on rapidly expanding, smaller-sized American businesses. Its objective is to closely mirror the performance of this index, which serves as a key indicator for the returns of small-capitalization growth-oriented companies within the U.S. market. While presenting substantial prospects for capital appreciation, its shares generally exhibit greater price fluctuations compared to investment vehicles focused on fixed-income securities. Consequently, it is best suited for investors pursuing enduring financial objectives where aggressive capital growth is a paramount concern.
Description from the fund data provider · profile as of Oct 13, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -3.77% | -6.68% | +4.47% | +9.44% | +11.52% | +18.14% | +3.62% | +9.48% | +10.49% |
| Total return | -3.77% | -6.68% | +4.63% | +9.76% | +12.15% | +18.86% | +4.33% | +10.21% | +11.23% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 12, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.06% | Annual cost of a $10,000 investment | $6.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 11, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 1138 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | SLBBH1142 | — | 1.42% | 250.22K | $25.0M |
| 2 | JFrog Ltd | FROG | 0.68% | 119.20K | $11.9M |
| 3 | Moog Inc | MOG-A | 0.66% | 31.27K | $11.6M |
| 4 | Glaukos Corp | GKOS | 0.64% | 62.96K | $11.3M |
| 5 | Brinker International Inc | EAT | 0.62% | 47.48K | $10.8M |
| 6 | BrightSpring Health Services Inc | BTSG | 0.59% | 178.16K | $10.4M |
| 7 | Krystal Biotech Inc | KRYS | 0.58% | 28.53K | $10.3M |
| 8 | Protagonist Therapeutics Inc | PTGX | 0.57% | 67.19K | $9.9M |
| 9 | Twist Bioscience Corp | TWST | 0.56% | 71.25K | $9.9M |
| 10 | FirstCash Holdings Inc | FCFS | 0.55% | 44.99K | $9.6M |
| 11 | Crinetics Pharmaceuticals Inc | CRNX | 0.55% | 113.21K | $9.6M |
| 12 | Praxis Precision Medicines Inc | PRAX | 0.55% | 27.44K | $9.6M |
| 13 | InterDigital Inc | IDCC | 0.54% | 28.53K | $9.6M |
| 14 | Ryman Hospitality Properties Inc | RHP | 0.53% | 74.10K | $9.4M |
| 15 | HealthEquity Inc | HQY | 0.51% | 92.63K | $8.9M |
| 16 | TG Therapeutics Inc | TGTX | 0.49% | 158.93K | $8.6M |
| 17 | StoneX Group Inc | SNEX | 0.46% | 119.27K | $8.2M |
| 18 | 10X Genomics Inc | TXG | 0.46% | 130.13K | $8.1M |
| 19 | Silicon Laboratories Inc | SLAB | 0.45% | 36.20K | $7.9M |
| 20 | ESCO Technologies Inc | ESE | 0.45% | 28.93K | $7.9M |
| 21 | Zurn Elkay Water Solutions Corp | ZWS | 0.45% | 165.10K | $7.9M |
| 22 | Oscar Health Inc | OSCR | 0.45% | 263.14K | $7.9M |
| 23 | Federal Signal Corp | FSS | 0.44% | 66.67K | $7.8M |
| 24 | Qualys Inc | QLYS | 0.42% | 39.73K | $7.4M |
| 25 | Spyre Therapeutics Inc | SYRE | 0.41% | 81.30K | $7.3M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.68% | Paid (last 12 months) | $1.7521 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 23, 2026 | Last payment | $0.3362 (Sep 25, 2026) |
| Growth 1Y | +39.37% | Growth 3Y / 5Y (ann.) | +5.69% / +13.73% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 23, 2026 | Sep 23, 2026 | Sep 25, 2026 | $0.3362 |
| Jun 18, 2026 | Jun 18, 2026 | Jun 23, 2026 | $0.4245 |
| Mar 24, 2026 | Mar 24, 2026 | Mar 26, 2026 | $0.3241 |
| Dec 22, 2025 | Dec 22, 2025 | Dec 24, 2025 | $0.6673 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 26, 2025 | $0.2542 |
| Jun 20, 2025 | Jun 20, 2025 | Jun 24, 2025 | $0.3786 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 27, 2025 | $0.2175 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 26, 2024 | $0.4069 |
| Sep 26, 2024 | Sep 26, 2024 | Sep 30, 2024 | $0.2265 |
| Jun 27, 2024 | Jun 27, 2024 | Jul 01, 2024 | $0.2654 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 26, 2024 | $0.2659 |
| Dec 19, 2023 | Dec 20, 2023 | Dec 22, 2023 | $0.4797 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 22.16% / 22.94% | Sharpe 1Y / 3Y | 0.493 / 0.79 |
| Max drawdown 1Y / 3Y | -14.88% / -28.58% | Sortino 1Y | 0.721 |
| Beta vs S&P 500 (3Y) | 1.25 | Correlation vs S&P 500 (1Y) | 0.832 |
| Downside deviation 1Y | 15.16% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 13, 2026. Formulas →
Liquidity
| Volume today | 17.70K | Average volume | 21.78K |
| AUM | $1.70B | Premium/Discount | -0.76% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $1.70B → $1.70B |
| 1 Month | $64.1M | +3.77% | $1.70B → $1.70B |
| 1 Week | $31.4M | +1.85% | $1.70B → $1.70B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for VTWG
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.